<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-06-02)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-06-02)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Plasma Exchange in Humans Reduces Biological Age by over Two Years</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-01</em></p>
<p>In a first, therapeutic plasma exchange combined with intravenous immunoglobin reduced biological age on average by 2.6 years, as measured by multi-omics biomarkers in a randomized, placebo-controlled, clinical trial. The post Plasma Exchange in Humans Reduces Biological Age by over Two Years app...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/plasma-exchange-in-humans-reduces-biological-age-by-over-two-years/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ASCO25: In race with Merus, Bicara makes the case for two-year survival data</h3>
<p class='source-date'><em>Endpoints News • 2025-06-01</em></p>
<p>CHICAGO — Forced to play defense after its stock price fell 40% last month on competing data, Bicara hopes to win back some favor with new results for its head and neck cancer drug. In the ...</p>
<p><a href='https://endpts.com/asco25-in-race-with-merus-bicara-makes-the-case-for-two-year-survival-data/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ASCO25: AstraZeneca details Phase 3 data for oral SERD 'switching' regimen</h3>
<p class='source-date'><em>Endpoints News • 2025-06-01</em></p>
<p>CHICAGO — AstraZeneca is planting its flag in the oral SERD space, touting positive Phase 3 breast cancer data for a program it expects to exceed more than $5 billion in annual peak sales. The trial ...</p>
<p><a href='https://endpts.com/asco25-astrazeneca-details-phase-3-data-for-oral-serd-switching-regimen/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ASCO25: Researchers debate how best to use checkpoint drugs in earlier cancers</h3>
<p class='source-date'><em>Endpoints News • 2025-06-01</em></p>
<p>CHICAGO — Checkpoint therapies, which made their name as treatments for patients with metastatic cancer, are now being implemented in a wide range of less-advanced cancers alongside surgery. The goal is not just to extend a ...</p>
<p><a href='https://endpts.com/asco25-researchers-debate-how-best-to-use-checkpoint-drugs-in-earlier-cancers/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ASCO25: Takeda, Protagonist unveil data for rare blood disease drug</h3>
<p class='source-date'><em>Endpoints News • 2025-06-01</em></p>
<p>CHICAGO — Takeda and Protagonist Therapeutics are on the comeback trail with rusfertide, almost four years after the rare blood disease drug was put on a clinical hold because of safety issues in animal studies. ...</p>
<p><a href='https://endpts.com/asco25-takeda-protagonist-unveil-data-for-rare-blood-disease-drug/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>FDA approves Moderna’s next-gen Covid vaccine</h3>
<p class='source-date'><em>Endpoints News • 2025-05-31</em></p>
<p>The FDA has approved Moderna’s next-generation Covid-19 vaccine, but said that people aged 12 to 64 should only get the shot if they have a health condition that puts them at risk from the virus ...</p>
<p><a href='https://endpts.com/fda-approves-modernas-next-gen-covid-vaccine/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Global trends and projections in antimicrobial resistance - Authors' reply.</h4>
<p class='source-date'><em>Mestrovic Tomislav, Hsu Rebecca, Swetschinski Lucien et al. | Lancet (London, England) • 2025-05-31</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/S0140-6736(25)00811-6' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Global trends and projections in antimicrobial resistance.</h4>
<p class='source-date'><em>Selvaraj Vimalraj, Sudhakar Swathi, Sekaran Saravanan | Lancet (London, England) • 2025-05-31</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/S0140-6736(25)00810-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Global trends and projections in antimicrobial resistance.</h4>
<p class='source-date'><em>Yang Liu Sylvia, Long Zhuowei, Chua Song Lin | Lancet (London, England) • 2025-05-31</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/S0140-6736(25)00809-8' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Global trends and projections in antimicrobial resistance.</h4>
<p class='source-date'><em>Fekadu Abebaw, Woldeamanuel Yimtubezinash, Hailu Asrat et al. | Lancet (London, England) • 2025-05-31</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/S0140-6736(25)00808-6' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Global trends and projections in antimicrobial resistance.</h4>
<p class='source-date'><em>Ma Edmond Siu-Keung, Wong Shuk-Ching, Cheng Vincent Chi-Chung et al. | Lancet (London, England) • 2025-05-31</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/S0140-6736(25)00807-4' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<div class='paper-item'>
<h4>Deciphering the role of Hashimoto's Thyroiditis-related key genes in thyroid cancer via detailed in silico analysis followed by the experimental validation.</h4>
<p class='source-date'><em>Abdel-Maksoud Mostafa A, Almana Taghreed N, Almutair Saeedah et al. | Hereditas • 2025-05-31</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Thyroid cancer, characterized by significant genetic and epigenetic alterations, remains a critical focus of molecular oncology. This study investigates eight key genes (BRAF, EIF1 AX, FOXE1, KRAS, PDGFRA, PIK3 CA, PTEN, and TERT) that are deregulated in Hashimoto's Thyroiditis and th...</p>
<p><a href='https://doi.org/10.1186/s41065-025-00429-0' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights.</h4>
<p class='source-date'><em>Zhang Li, Yang Yang, Li Yanchu et al. | Biomarker research • 2025-05-31</em></p>
<p><strong>Abstract:</strong> Glioblastoma (GBM) is the most common primary malignant brain tumor, characterized by its aggressive behavior, limited treatment options, and poor prognosis. Despite advances in surgery, radiotherapy, and chemotherapy, the median survival of GBM patients remains disappointingly short. Recent stud...</p>
<p><a href='https://doi.org/10.1186/s40364-025-00788-w' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Modulatory effect of metformin and its transporters on immune infiltration in tumor microenvironment: a bioinformatic study with experimental validation.</h4>
<p class='source-date'><em>Rashad Ahmed A, Elshafie Mohamed F, Mangoura Safwat A et al. | Discover oncology • 2025-05-31</em></p>
<p><strong>Abstract:</strong> Metformin is a traditional antidiabetic drug for type 2 diabetes mellitus. However, it showed antitumor activity in many types of tumors, and it also has an influence on tumor metastasis in several types of tumors. It is transported through organic cationic transporters (OCTs), OCT1, OCT2, and OC...</p>
<p><a href='https://doi.org/10.1007/s12672-025-02766-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Antero-posterior patterning in the brittle star Amphipholis squamata and the evolution of echinoderm body plans.</h4>
<p class='source-date'><em>Formery L, Peluso P, Rank D R et al. | EvoDevo • 2025-05-31</em></p>
<p><strong>Abstract:</strong> Although the adult pentaradial body plan of echinoderms evolved from a bilateral ancestor, identifying axial homologies between the morphologically divergent echinoderms and their bilaterian relatives has been an enduring problem in zoology. The expression of conserved bilaterian patterning genes...</p>
<p><a href='https://doi.org/10.1186/s13227-025-00244-8' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Astragalus polysaccharide protects against cardiac injury in a tnnt2a mutant zebrafish model of dilated cardiomyopathy.</h4>
<p class='source-date'><em>Zhou Chang, Zhao Hui, Peng Longping et al. | BMC complementary medicine and therapies • 2025-05-31</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Dilated cardiomyopathy (DCM) is a severe and irreversible heart disease characterized by dilated ventricles and decreased myocardial function. DCM has a poor prognosis and a very low survival rate, with a 5-year mortality rate ranging from 15 to 50%, and is an important cause of sudde...</p>
<p><a href='https://doi.org/10.1186/s12906-025-04925-8' target='_blank'>View Paper</a></p>
</div>
<h3>Bacteriophage Research Papers</h3>
<p>No recent papers on Bacteriophage Research available today.</p>
<h3>Skin Microbiome & Disease Papers</h3>
<div class='paper-item'>
<h4>Confounders of the skin microbiome and wound healing in burn patients.</h4>
<p class='source-date'><em>Pourali Alireza, Aali Shahab, Kamrava Amirhosein | Burns : journal of the International Society for Burn Injuries • 2025-06-01</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/j.burns.2025.107450' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Targeting the Cutibacterium acnes Biofilm in Acne.</h4>
<p class='source-date'><em>Scott Emma, Bullerjahn George S, Burkhart Craig G | International journal of dermatology • 2025-06-01</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1111/ijd.17752' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Full-length 16S rRNA-based exploration of body site-specific bacterial signatures for origin determination and individual identification.</h4>
<p class='source-date'><em>Lei Yinlei, Deng Yu, Xia Ruocheng et al. | Forensic science international • 2025-06-01</em></p>
<p><strong>Abstract:</strong> When the available human-derived information at a crime scene is limited, it poses challenges in determining the origin of the biological materials and identifying their donors. In this context, microorganisms have gradually emerged as a valuable complementary tool. Nowadays, the application of t...</p>
<p><a href='https://doi.org/10.1016/j.forsciint.2025.112475' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>ZnO colludes with C. acnes in healing delay and Scar hyperplasia by barrier destruction.</h4>
<p class='source-date'><em>Zhang Fenglan, Wang Tianyi, Wang Wenqiao et al. | Journal of nanobiotechnology • 2025-05-31</em></p>
<p><strong>Abstract:</strong> As an important component of sunscreen products for sensitive skin, the potential damage mechanism of ZnO nanoparticles on skin surface with barrier structure or function defect caused by Cutibacterium acnes (C. acnes) has not been elucidated, which poses a serious challenge for reasonable select...</p>
<p><a href='https://doi.org/10.1186/s12951-025-03414-x' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Body-site specific associations between human skin microbiome composition and psychological wellbeing.</h4>
<p class='source-date'><em>Tyson-Carr John, Leng Joy, Scott Margaret et al. | The British journal of dermatology • 2025-05-26</em></p>
<p><strong>Abstract:</strong> BACKGROUND/OBJECTIVES: There is increasing scientific interest in understanding the interplay between psychological wellbeing and the human microbiome, with a particular focus on the gut microbiome's impact on psychological health. However, the role of the skin microbiome remains underexplored. T...</p>
<p><a href='https://doi.org/10.1093/bjd/ljaf177' target='_blank'>View Paper</a></p>
</div>
<hr>
<p><em>Report generated on 2025-06-02</em></p>
</div>
</body>
</html>